First Biologic Treatment for Deadly Type of Skin Cancer Gets Strong Positive Recommendation to be Covered by Provincial Health Care

First Biologic Treatment for Deadly Type of Skin Cancer Gets Strong Positive Recommendation to be Covered by Provincial Health Care Save Your Skin Foundation Applauds the pan-Canadian Oncology Drug Review recommendation for Provincial Reimbursement of LibtayoTM, the first and only biologic for the treatment of Advanced Cutaneous Squamous Cell Carcinoma TORONTO, Jan. 15, 2020 /CNW/ – Save … Continue reading First Biologic Treatment for Deadly Type of Skin Cancer Gets Strong Positive Recommendation to be Covered by Provincial Health Care

Stanford Inn and Resort Offers Personalized Family Workshops to Help Overcome Picky Eatin

Stanford Inn and Resort Offers Personalized Family Workshops to Help Overcome Picky Eating   At this plant-based Mendocino resort children and parents cook together, learn nutrition as a team, and participate in family art and creativity workshops to build long-term healthy living habits MENDOCINO, CA _ The Stanford Inn and Resort, is offering families a chance to grab … Continue reading Stanford Inn and Resort Offers Personalized Family Workshops to Help Overcome Picky Eatin

Best Couple Health and Fitness Escapes for Valentine’s Day

Best Couple Health and Fitness Escapes for Valentine’s Day With Valentine’s Day approaching, rediscover romance with the best Valentine’s Day wellness breaks to suit every couple. From adventure-loving, Globetrotting and sporty couples to those looking to rediscover their zen this Valentine’s Day, Health and Fitness Travel, the wellness holiday specialists has hand-picked the best health and … Continue reading Best Couple Health and Fitness Escapes for Valentine’s Day

Health Canada Approves Astellas’ XOSPATA® (gilteritinib) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

Health Canada Approves Astellas’ XOSPATA® (gilteritinib) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation XOSPATA is the first and only targeted treatment approved by Health Canada for patients with relapsed or refractory Acute Myeloid Leukemia with a FLT3 mutation. The approval of XOSPATA marks Astellas’ Canadian entry into the treatment of blood … Continue reading Health Canada Approves Astellas’ XOSPATA® (gilteritinib) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

AbbVie’s MAVIRET® now listed on the Newfoundland and Labrador formulary

AbbVie’s MAVIRET® now listed on the Newfoundland and Labrador formulary MAVIRET® is an 8-week, pan-genotypic treatment for adults and adolescent patients 12 to 18 years of age with chronic hepatitis C virus (HCV) infection without cirrhosis and who are new to treatment.*1 MAVIRET is approved for use in patients across all stages of chronic kidney … Continue reading AbbVie’s MAVIRET® now listed on the Newfoundland and Labrador formulary